NATCO Pharma has informed that it enclosed the disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the information that the officials of the Company will be participating in meeting with investor ‘BoB Capital Markets’ (In-person) on 28th February 2025 at 3:30 pm at Hyderabad. No Unpublished price Sensitive Information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.
